Miscellaneous vitreous-derived IgM antibodies target numerous retinal proteins in equine recurrent uveitis

Veterinary Ophthalmology

Volumn 15, Issue SUPPL.2, 2012, Pages 57-64

  Zipplies, Johanna K ^a   Hauck, Stefanie M ^b   Eberhardt, Christina ^a   Hirmer, Sieglinde ^a   Amann, Barbara ^a   Stangassinger, Manfred ^a   Ueffing, Marius ^b,c   Deeg, Cornelia A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Autoantibody; Immune response; Intraocular IgM; Mass spectrometry; Retina; Vitreous

Indexed keywords

AUTOANTIBODY; EYE PROTEIN; IMMUNOGLOBULIN M; PROTEOME;

ANIMAL; ANIMAL DISEASE; ARTICLE; HORSE; HORSE DISEASE; IMMUNOLOGY; PATHOLOGY; RETINA; UVEITIS;

ANIMALS; AUTOANTIBODIES; EYE PROTEINS; HORSE DISEASES; HORSES; IMMUNOGLOBULIN M; PROTEOME; RETINA; UVEITIS;

EQUIDAE;

EID: 84865757523     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2012.01010.x     Document Type: Article

References (52)

1. Deeg CA, Hauck SM, Amann B et al. Equine recurrent uveitis - a spontaneous horse model of uveitis. Ophthalmic Research 2008; 40: 151-153.
2. Spiess BM. Equine recurrent uveitis: the European viewpoint. Equine Veterinary Journal 2010; 42(Suppl 37): 50-56.
3. Gilger BC, Malok E, Cutter KV et al. Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis. Veterinary Immunology and Immunopathology 1999; 71: 17-28.
4. Gilger BC. Equine recurrent uveitis: the viewpoint from the USA. Equine Veterinary Journal 2010; 42(Suppl 37): 57-61.
5. Deeg CA, Pompetzki D, Raith AJ et al. Identification and functional validation of novel autoantigens in equine uveitis. Molecular and Cellular Proteomics 2006; 5: 1462-1470.
6. Deeg CA, Reese S, Gerhards H et al. The uveitogenic potential of retinal S-antigen in horses. Investigative Ophthalmology & Visual Science 2004; 45: 2286-2292.
7. Deeg CA, Thurau SR, Gerhards H et al. Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease. European Journal of Immunology 2002; 32: 2598-2606.
8. Forrester JV. Uveitis: pathogenesis. Lancet 1991; 338: 1498-1501.
9. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nature Reviews Immunology 2002; 2: 85-95.
10. Powell AM, Black MM. Epitope spreading: protection from pathogens, but propagation of autoimmunity? Clinical and Experimental Dermatology 2001; 26: 427-433.
11. Deeg CA, Amann B, Raith AJ et al. Inter- and intramolecular epitope spreading in equine recurrent uveitis. Investigative Ophthalmology & Visual Science 2006; 47: 652-656.
12. Hofmaier F, Hauck SM, Amann B et al. Changes in matrix metalloproteinase network in spontaneous autoimmune uveitis model. Investigative Ophthalmology & Visual Science 2011; 52(5): 2314-2320.
13. Deeg CA, Kaspers B, Gerhards H et al. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Investigative Ophthalmology & Visual Science 2001; 42: 393-398.
14. Elkon K, Casali P. Nature and functions of autoantibodies. Nature Clinical Practice Rheumatology 2008; 4: 491-498.
15. Quintana FJ, Cohen IR. The natural autoantibody repertoire and autoimmune disease. Biomedicine & Pharmacotherapy 2004; 58: 276-281.
16. Hauck SM, Schoeffmann S, Amann B et al. Retinal Mueller glial cells trigger the hallmark inflammatory process in autoimmune uveitis. Journal of Proteome Research 2007; 6: 2121-2131.
17. Keller A, Nesvizhskii AI, Kolker E et al. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Analytical Chemistry 2002; 74: 5383-5392 [doi: 10.1021/ac025747h].
18. Alonso A, Bearra A, Scavini LM et al. Immunological findings in human beings with autoimmune uveitis. Allergologia et Immunopathologia 1988; 16: 417-420.
19. Patel N, Ohbayashi M, Nugent AK et al. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 2005; 115: 422-430.
20. Hooks JJ, Tso MO, Detrick B. Retinopathies associated with antiretinal antibodies. Clinical and Diagnostic Laboratory Immunology 2001; 8: 853-858.
21. Kijlstra A, Hoekzema R, Lelij A et al. Humoral and cellular immune reactions against retinal antigens in clinical disease. Current Eye Research 1990; 9(Suppl): 85-89.
22. Caspi RR, Roberge FG, McAllister CG et al. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. Journal of Immunology 1986; 136: 928-933.
23. De Kozak Y, Mirshahi M, Boucheix C et al. Prevention of experimental autoimmune uveoretinitis by active immunization with autoantigen-specific monoclonal antibodies. European Journal of Immunology 1987; 17: 541-547.
24. Scofield RH. Autoantibodies as predictors of disease. Lancet 2004; 363: 1544-1546.
25. Caspi RR. Ocular autoimmunity: the price of privilege? Immunological Reviews 2006; 213: 23-35.
26. Deeg CA, Altmann F, Hauck SM et al. Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier. Proteomics 2007; 7: 1540-1548.
27. Sen DK, Sarin GS, Saha K. Immunoglobulins in human aqueous humour. British Journal of Ophthalmology 1977; 61: 216-217.
28. Matthews AG, Poulter T. Albumin and immunoglobulins G, A and M in aqueous humour from clinically normal equine eyes. Equine Veterinary Journal 1986; 18: 117-120.
29. Yang P, Chen L, Zwart R et al. Immune cells in the porcine retina: distribution, characterization and morphological features. Investigative Ophthalmology & Visual Science 2002; 43: 1488-1492.
30. Yang P, Das PK, Kijlstra A. Localization and characterization of immunocompetent cells in the human retina. Ocular Immunology and Inflammation 2000; 8: 149-157.
31. Deeg CA, Ehrenhofer M, Thurau SR et al. Immunopathology of recurrent uveitis in spontaneously diseased horses. Experimental Eye Research 2002; 75: 127-133.
32. Moulds JM. Introduction to antibodies and complement. Transfusion and Apheresis Science 2009; 40: 185-188.
33. Gros P, Milder FJ, Janssen BJ. Complement driven by conformational changes. Nature Reviews Immunology 2008; 8: 48-58.
34. Bora NS, Jha P, Bora PS. The role of complement in ocular pathology. Seminars in Immunopathology 2008; 30(2): 85-95.
35. Zipplies JK, Kirschfink M, Amann B et al. Complement factor B expression profile in a spontaneous uveitis model. Immunobiology 2010; 215(12): 949-955.
36. Carroll MC. The complement system in regulation of adaptive immunity. Nature Immunology 2004; 5: 981-986.
37. Carroll MC. The complement system in B cell regulation. Molecular Immunology 2004; 41: 141-146.
38. Boes M. Role of natural and immune IgM antibodies in immune responses. Molecular Immunology 2000; 37: 1141-1149.
39. Terrier B, Degand N, Guilpain P et al. Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmunity Reviews 2007; 6: 176-182.
40. Ren G, Adamus G. Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy. Journal of Autoimmunity 2004; 23: 161-167.
41. Braus BK, Hauck SM, Amann B et al. Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome. Veterinary Immunology and Immunopathology 2008; 124: 177-183.
42. Wierenga RK, Kapetaniou EG, Venkatesan R. Triosephosphate isomerase: a highly evolved biocatalyst. Cellular and Molecular Life Sciences 2010; 67: 3961-3982.
43. Kolln J, Ren H-M, Da R-R et al. Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis. The Journal of Immunology 2006; 177: 5652-5658.
44. Obsilova V, Silhan J, Boura E et al. 14-3-3 proteins: a family of versatile molecular regulators. Physiological Research 2008; 57(Suppl 3): S11-S21.
45. Berg D, Holzmann C, Riess O. 14-3-3 proteins in the nervous system. Nature Reviews Neuroscience 2003; 4: 752-762.
46. Imai H, Ohta K, Yoshida A et al. {mu}-Crystallin, new candidate protein in endotoxin-induced uveitis. Investigative Ophthalmology & Visual Science 2010; 51: 3554-3559.
47. Meri S, Baumann M. Proteomics: posttranslational modifications, immune responses and current analytical tools. Biomolecular Engineering 2001; 18: 213-220.
48. Rajaiah R, Moudgil KD. Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmunity Reviews 2009; 8: 388-393.
49. Li Z, Menoret A, Srivastava P. Roles of heat-shock proteins in antigen presentation and cross-presentation. Current Opinion in Immunology 2002; 14: 45-51.
50. Wang Y, Kelly CG, Singh M et al. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. Journal of Immunology 2002; 169: 2422-2429.
51. Eberhardt C, Amann B, Feuchtinger A et al. Differential expression of inwardly rectifying K+ channels and aquaporins 4 and 5 in autoimmune uveitis indicates misbalance in Muller glial cell-dependent ion and water homeostasis. Glia 2011; 59: 697-707.
52. Swadzba ME, Hirmer S, Amann B et al. Vitreal IgM autoantibodies target neurofilament medium in a spontaneous model of autoimmune uveitis. Investigative Ophthalmology & Visual Science 2012; 53: 294-300.